Global Healthcare Valuation

GBCS Stock  USD 2.00  0.00  0.00%   
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Global Healthcare REIT retains a regular Real Value of $2.3 per share. The prevalent price of the firm is $2.0. Our model calculates the value of Global Healthcare REIT from evaluating the firm fundamentals such as Current Valuation of 50.96 M, return on asset of -2.0E-4, and Return On Equity of -0.6 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
2.00
2.022.32.32.0211.81100%
Please note that Global Healthcare's price fluctuation is dangerous at this time. Calculation of the real value of Global Healthcare REIT is based on 3 months time horizon. Increasing Global Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Global pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Global Healthcare REIT. Since Global Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Global Pink Sheet. However, Global Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  2.0 Real  2.3 Hype  2.0 Naive  1.81
The intrinsic value of Global Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Global Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
2.30
Real Value
11.06
Upside
Estimating the potential upside or downside of Global Healthcare REIT helps investors to forecast how Global pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Global Healthcare more accurately as focusing exclusively on Global Healthcare's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.661.902.15
Details
Hype
Prediction
LowEstimatedHigh
0.102.0010.76
Details
Naive
Forecast
LowNext ValueHigh
0.041.8110.56
Details

Global Healthcare Total Value Analysis

Global Healthcare REIT is currently forecasted to have valuation of 50.96 M with market capitalization of 14.57 M, debt of 31.8 M, and cash on hands of 2.96 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Global Healthcare fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
50.96 M
14.57 M
31.8 M
2.96 M

Global Healthcare Investor Information

About 25.0% of the company shares are held by company insiders. The book value of Global Healthcare was currently reported as 0.79. The company last dividend was issued on the 20th of July 2015. Global Healthcare REIT had 1:10 split on the 22nd of September 2021. Based on the measurements of operating efficiency obtained from Global Healthcare's historical financial statements, Global Healthcare REIT is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.

Global Healthcare Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Global implies not a very effective usage of assets in February.

Global Healthcare Ownership Allocation

The market capitalization of Global Healthcare is $14.57 Million. Global Healthcare secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Public75.03%Insiders24.97%100%

Global Healthcare Profitability Analysis

The company reported the previous year's revenue of 27.77 M. Net Loss for the year was (2.24 M) with profit before overhead, payroll, taxes, and interest of 7.81 M.
27.8M7.8M2.0M-2.2M-13.7M100%

About Global Healthcare Valuation

The pink sheet valuation mechanism determines Global Healthcare's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Global Healthcare REIT based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Global Healthcare. We calculate exposure to Global Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Global Healthcare's related companies.
was organized with the intent of operating as a real estate investment trust for the purpose of investing in real estate and other assets related to the healthcare industry. The Company operates the facilities internally when advantageous and expedient. Selectis Health operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 503 people.

8 Steps to conduct Global Healthcare's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Global Healthcare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Global Healthcare's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Global Healthcare's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Global Healthcare's revenue streams: Identify Global Healthcare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Global Healthcare's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Global Healthcare's growth potential: Evaluate Global Healthcare's management, business model, and growth potential.
  • Determine Global Healthcare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Global Healthcare's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Global Healthcare Growth Indicators

Investing in growth stocks can be very risky. If the company such as Global Healthcare does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding2.8 M
Quarterly Earnings Growth Y O Y3.584
Retained Earnings-11.3 M

Additional Tools for Global Pink Sheet Analysis

When running Global Healthcare's price analysis, check to measure Global Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Healthcare is operating at the current time. Most of Global Healthcare's value examination focuses on studying past and present price action to predict the probability of Global Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Healthcare's price. Additionally, you may evaluate how the addition of Global Healthcare to your portfolios can decrease your overall portfolio volatility.